These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24274866)

  • 21. Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
    Adams LA; Angulo P
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1059-60. PubMed ID: 15625648
    [No Abstract]   [Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
    Parikh N; Ahmad J
    Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
    Bugianesi E; Marzocchi R; Villanova N; Marchesini G
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence.
    Tang JT; Mao YM
    J Dig Dis; 2017 Nov; 18(11):607-617. PubMed ID: 29106066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug therapy for non-alcoholic steatohepatitis].
    Tomita K; Hibi T
    Nihon Rinsho; 2006 Jun; 64(6):1146-51. PubMed ID: 16768123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy for nonalcoholic fatty liver disease].
    Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):139. PubMed ID: 15727706
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE.
    Robinson JG
    Curr Atheroscler Rep; 2007 Jan; 9(1):64-71. PubMed ID: 17169249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of fatty liver disease].
    Cobo Martín M; Fernández Gil P; Crespo J
    Gastroenterol Hepatol; 2008 Apr; 31(4):229-38. PubMed ID: 18405489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of NAFLD: insulin sensitizing agents.
    Caldwell SH; Argo CK; Al-Osaimi AM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S61-6. PubMed ID: 16540770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of NAFLD.
    Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H; Kaser A
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):148-55. PubMed ID: 16265156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current treatment strategies for non-alcoholic fatty liver disease (NAFLD).
    Mishra P; Younossi ZM
    Curr Drug Discov Technol; 2007 Aug; 4(2):133-40. PubMed ID: 17691915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance and PPAR insulin sensitizers.
    Bhatia V; Viswanathan P
    Curr Opin Investig Drugs; 2006 Oct; 7(10):891-7. PubMed ID: 17086933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin sensitizers in nonalcoholic steatohepatitis.
    Harrison SA; Schenker S; Cusi K
    Hepatology; 2011 Apr; 53(4):1404-5; author reply 1405. PubMed ID: 21480350
    [No Abstract]   [Full Text] [Related]  

  • 35. Current Pharmacologic Therapy for Nonalcoholic Fatty Liver Disease.
    Ganesh S; Rustgi VK
    Clin Liver Dis; 2016 May; 20(2):351-64. PubMed ID: 27063274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease.
    Kadayifci A; Merriman RB
    Am J Gastroenterol; 2006 Jun; 101(6):1396; author reply 1396-7. PubMed ID: 16771968
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of metformin in the management of NAFLD.
    Mazza A; Fruci B; Garinis GA; Giuliano S; Malaguarnera R; Belfiore A
    Exp Diabetes Res; 2012; 2012():716404. PubMed ID: 22194737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment of non-alcoholic fatty liver disease.
    Ahmed MH; Byrne CD
    Diabetes Obes Metab; 2009 Mar; 11(3):188-95. PubMed ID: 18564173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeuric aspects of NAFLD. A literature review].
    Tapia NC; Avila FI; Leiva JG; Ramos MH; Avila JF; Uribe M
    Rev Gastroenterol Mex; 2006; 71(4):487-95. PubMed ID: 17542283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis].
    Timmer A
    Z Gastroenterol; 2007 Feb; 45(2):191-3. PubMed ID: 17304406
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.